scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2362.2003.01135.X |
P698 | PubMed publication ID | 12641538 |
P50 | author | Casper G. Schalkwijk | Q76998834 |
P2093 | author name string | van den Berg M | |
Twisk JW | |||
Stehouwer CD | |||
Rauwerda JA | |||
de Jong SC | |||
Vermeulen EG | |||
P2860 | cites work | Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study | Q57830035 |
Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study | Q28141937 | ||
Homocysteine and cardiovascular disease | Q28265188 | ||
Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules | Q28365442 | ||
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
Endogenous tissue-type plasminogen activator and risk of myocardial infarction | Q41079493 | ||
Endothelial dysfunction and pathogenesis of diabetic angiopathy | Q41526683 | ||
Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey | Q41914147 | ||
Features of endothelial dysfunction in early diabetic nephropathy | Q42494570 | ||
Association between albumin:creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension | Q43596946 | ||
Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. | Q50926553 | ||
Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. | Q50970547 | ||
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. | Q51558185 | ||
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes | Q56171250 | ||
P433 | issue | 3 | |
P921 | main subject | endothelium | Q111140 |
folic acid | Q127060 | ||
vitamin B | Q183206 | ||
pyridoxine | Q423746 | ||
vitamin B6 | Q205130 | ||
P304 | page(s) | 209-215 | |
P577 | publication date | 2003-03-01 | |
P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
P1476 | title | Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial | |
P478 | volume | 33 |
Q37452734 | Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas |
Q35600418 | Does homocysteine cause hypertension? |
Q55499367 | Effect of Combined Treatment With Folic Acid, Vitamin B6, and Vitamin B12 on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women. |
Q59150479 | Homocysteine and vitamin B12 concentrations and mortality rates in type 2 diabetes |
Q36273319 | Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patients |
Q33727314 | Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort |
Q83193282 | No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease |
Q35830086 | Nutrition and prevention of ischemic stroke: present knowledge, limitations and future perspectives |
Q93161742 | Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study |
Search more.